Chak-Kwong Cheng - Search Results

Year	Number of Results
2017	1
2018	4
2019	3
2020	2
2021	6
2022	6
2023	9
2024	1

1

Targeting endothelial dysfunction and inflammation.

Wang L, Cheng CK, Yi M, Lui KO, Huang Y. Wang L, et al. Among authors: cheng ck. J Mol Cell Cardiol. 2022 Jul;168:58-67. doi: 10.1016/j.yjmcc.2022.04.011. Epub 2022 Apr 20. J Mol Cell Cardiol. 2022. PMID: 35460762 Review.

2

Endothelial UCP2 Is a Mechanosensitive Suppressor of Atherosclerosis.

Luo JY, Cheng CK, He L, Pu Y, Zhang Y, Lin X, Xu A, Lau CW, Tian XY, Ma RCW, Jo H, Huang Y. Luo JY, et al. Among authors: cheng ck. Circ Res. 2022 Aug 19;131(5):424-441. doi: 10.1161/CIRCRESAHA.122.321187. Epub 2022 Jul 28. Circ Res. 2022. PMID: 35899624 Free PMC article.

3

Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives.

Wang Y, Jin M, Cheng CK, Li Q. Wang Y, et al. Among authors: cheng ck. Front Endocrinol (Lausanne). 2023 Aug 2;14:1238927. doi: 10.3389/fendo.2023.1238927. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37600689 Free PMC article. Review.

4

SOX4 is a novel phenotypic regulator of endothelial cells in atherosclerosis revealed by single-cell analysis.

Cheng CK, Lin X, Pu Y, Tse JKY, Wang Y, Zhang CL, Cao X, Lau CW, Huang J, He L, Luo JY, Shih YT, Wan S, Ng CF, Wang L, Ma RCW, Chiu JJ, Chan TF, Yu Tian X, Huang Y. Cheng CK, et al. J Adv Res. 2023 Jan;43:187-203. doi: 10.1016/j.jare.2022.02.017. Epub 2022 Mar 1. J Adv Res. 2023. PMID: 36585108 Free PMC article.

5

Perivascular adipose tissue: Fine-tuner of vascular redox status and inflammation.

Cheng CK, Ding H, Jiang M, Yin H, Gollasch M, Huang Y. Cheng CK, et al. Redox Biol. 2023 Jun;62:102683. doi: 10.1016/j.redox.2023.102683. Epub 2023 Mar 20. Redox Biol. 2023. PMID: 36958248 Free PMC article. Review.

6

Endogenous and microbial biomarkers for periodontitis and type 2 diabetes mellitus.

Li S, Li H, Kong H, Wu SY, Cheng CK, Xu J. Li S, et al. Among authors: cheng ck. Front Endocrinol (Lausanne). 2023 Dec 5;14:1292596. doi: 10.3389/fendo.2023.1292596. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38149100 Free PMC article. Review.

7

Recent Advances in Managing Atherosclerosis via Nanomedicine.

Chan CKW, Zhang L, Cheng CK, Yang H, Huang Y, Tian XY, Choi CHJ. Chan CKW, et al. Among authors: cheng ck. Small. 2018 Jan;14(4). doi: 10.1002/smll.201702793. Epub 2017 Dec 14. Small. 2018. PMID: 29239134 Review.

8

Molecular mechanisms and therapeutic perspectives of peroxisome proliferator-activated receptor α agonists in cardiovascular health and disease.

Pu Y, Cheng CK, Zhang H, Luo JY, Wang L, Tomlinson B, Huang Y. Pu Y, et al. Among authors: cheng ck. Med Res Rev. 2023 Nov;43(6):2086-2114. doi: 10.1002/med.21970. Epub 2023 Apr 29. Med Res Rev. 2023. PMID: 37119045 Review.

9

The gut-cardiovascular connection: new era for cardiovascular therapy.

Cheng CK, Huang Y. Cheng CK, et al. Med Rev (2021). 2021 Oct 21;1(1):23-46. doi: 10.1515/mr-2021-0002. eCollection 2021 Oct. Med Rev (2021). 2021. PMID: 37724079 Free PMC article. Review.

10

Induction of KLF2 by Exercise Activates eNOS to Improve Vasodilatation in Diabetic Mice.

Luo JY, Cheng CK, Gou L, He L, Zhao L, Zhang Y, Wang L, Lau CW, Xu A, Chen AF, Huang Y. Luo JY, et al. Among authors: cheng ck. Diabetes. 2023 Sep 1;72(9):1330-1342. doi: 10.2337/db23-0070. Diabetes. 2023. PMID: 37347764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year